Tags: Earns Johnson andJohnson

J&J Profit Falls as Product Recalls Drag on Sales

Tuesday, 25 Jan 2011 09:01 AM

Healthcare giant Johnson & Johnson, hammered by numerous recalls that have kept some products off the market, reports a 12 percent profit decline and a 5.5 percent drop in revenue for the fourth quarter.

The maker of Tylenol, medical devices and biologic drugs said Tuesday net income was $1.94 billion, or 70 cents per share.

But excluding one-time items, its earnings would have been $1.03 per share, matching analysts' expectations.

It says revenue fell to $15.6 billion, slightly below the $16.02 billion expected by analysts.

Sales of consumer products such as Tylenol, Benadryl and Rolaids — all the subject of recalls over product contamination and other problems — were down the most. Sales in that division fell 15 percent.

Its shares slipped 1.5 percent to $61.37 in pre-market trading.

© Copyright 2017 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

1Like our page
2Share
Companies
Healthcare giant Johnson Johnson, hammered by numerous recalls that have kept some products off the market, reports a 12 percent profit decline and a 5.5 percent drop in revenue for the fourth quarter.The maker of Tylenol, medical devices and biologic drugs said Tuesday...
Earns Johnson andJohnson
127
2011-01-25
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved